Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress
- Successful filing of S1 registration statement with SEC
- Progress in clinical trials process for TBX FREE and TBX VAPE FREE
- None.
Mr. Cardiff further provided updates on the progress of the clinical trials process for TBX FREE and TBX VAPE FREE. He stated, "In our unwavering commitment to advancing medical science and enhancing customer outcomes, we have made substantial strides in our clinical trials process. We have now finalized the Institutional Review Board (IRB) documents required for submission, in accordance with the guidelines of the Food and Drug Administration (FDA). We eagerly anticipate delivering comprehensive scientific data that will benefit customers and healthcare providers alike."
For further information, please contact:
Email: Info@redwoodsci.co
Phone: 646-503-7884
View original content to download multimedia:https://www.prnewswire.com/news-releases/redwood-scientific-technologies-inc-rsciotcpk-announces-successful-s1-registration-filing-and-provides-updates-on-tbx-free-clinical-trial-progress-301930457.html
SOURCE Redwood Scientific Technologies Inc.